<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Osiris Therapeutics Inc. | Company News & Executive Profiles - OSIR | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/osiris+therapeutics+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Osiris Therapeutics Inc.]]></description>
	<s:counts start="0" returned="10" found="22" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Expiration Trade Behind Osiris Activity]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F174610-expiration-trade-behind-osiris-activity%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[optionMONSTER submits:  By Chris McKhann As we close in on expiration at the end of today's session, traders are rolling out positions that they don't want to be without going into Monday. That's what we are seeing today in Osiris Therapeutics OSIR, where traders are rolling put positions out...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 20 Nov 2009 11:26:50 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/optionmonster.html"><![CDATA[optionMONSTER]]></category>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="tickers">OSIR</category>
	</item>
	<item>
		<title><![CDATA[Optimistic on Osiris Therapeutics]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F136491-optimistic-on-osiris-therapeutics%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   By: Jason Napodano, CFA Osiris Therapeutics, Inc. OSIR reported financial results for the first quarter 2009 on May 7, 2009. Total revenues in the quarter were $12.7 million, up from $0.4 million for the same period for 2008, and slightly above our forecasts of $11.8 million....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 08 May 2009 05:59:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="tickers">OSIR</category>
	</item>
	<item>
		<title><![CDATA[Osiris Hits a Speedbump in Crohn's Program]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F128252-osiris-hits-a-speedbump-in-crohn-s-program%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   On March 27, 2009, Osiris Therapeutics OSIR announced it was stopping its phase III clinical trial program testing Prochymal for the treatment of acute Crohn&#8217;s disease CD due to a design flaw in the trial that was allowing for significantly higher-than-expected placebo response rates.The decision was...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 27 Mar 2009 10:05:54 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="tickers">GENZ,OSIR</category>
	</item>
	<item>
		<title><![CDATA[Osiris Therapeutics, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-273688.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions We'll go first to Bill Tanner with Leerink Swann. Bill Tanner &#8211; Leerink Swann Thanks. Randy, just a few questions I guess on the Prochymal programs. First on the GvHD, can you just maybe put a little bit more detail on the anticipated calendar? I...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 27 Feb 2009 10:40:34 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/module.html"><![CDATA[Module]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="tickers">OSIR</category>
	</item>
	<item>
		<title><![CDATA[Osiris Therapeutics Enters a New Age of Pharma Risk and Profit Share]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F119208-osiris-therapeutics-enters-a-new-age-of-pharma-risk-and-profit-share%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Dusan Bogunovic submits:   Technology &#8211; Strong 47 patent position   Osiris OSIR was founded on the basis of technology that promised development of stem cell treatments. More precisely that meant Dr. Caplan one of the founders first described cells that were stuck to the plate, after culturing...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 08 Feb 2009 08:15:16 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/dusan+bogunovic.html"><![CDATA[Dusan Bogunovic]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="tickers">GENZ,OSIR</category>
	</item>
	<item>
		<title><![CDATA[Genzyme and Osiris Get Together on Stem Cells]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F104085-genzyme-and-osiris-get-together-on-stem-cells%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  In a bit of an election-day irony, a pretty significant stem cell deal is grabbing headlines in the biopharma sector. While it definitely took a back seat to the economy this election cycle, stem cell research has long been a hot-button political issue. John McCain supports...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 05 Nov 2008 12:27:05 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/stem-cell.html"><![CDATA[Stem-cell]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/barack+obama.html"><![CDATA[Barack Obama]]></category>
		<category domain="http://resources.bnet.com/topic/mike+huckman.html"><![CDATA[Mike Huckman]]></category>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="tickers">GENZ,OSIR</category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Blog Highlights: Forest Laboratories, Inc., CarMax, Applied Micro Circuits Corp., Cabot Oil & Gas Corp. and Osiris Therapeutics, Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_25/ai_n28581029]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Forest Laboratories, Inc. (NYSE: FRX), CarMax, Inc. (NYSE: KMX), Applied Micro...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 25 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/analyst.html"><![CDATA[analyst]]></category>
		<category domain="http://resources.bnet.com/topic/applied+micro+circuits+corp..html"><![CDATA[Applied Micro Circuits Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/blog.html"><![CDATA[blog]]></category>
		<category domain="http://resources.bnet.com/topic/cabot+oil+%2526+gas+corp..html"><![CDATA[Cabot Oil & Gas Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/carmax+inc..html"><![CDATA[CarMax Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/newsletter.html"><![CDATA[newsletter]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">COG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KMX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="tickers">AMCC,COG,KMX,FRX,NDAQ,OSIR</category>
	</item>
	<item>
		<title><![CDATA[Osiris Therapeutics, Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-226337.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. We will take our first question from Bill Tanner with Leerink Swann. Bill Tanner - Leerink Swann Thanks, couple of questions Randy. Just first on the NuVasive agreement, just curious if Orthofix was in the mix, in terms of looking at Osteocel. It seems like...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 30 May 2008 07:19:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="tickers">OSIR</category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Blog Highlights: VeriSign, Google, Osiris Therapeutics, Genzyme and Penn Virginia Resource Partners]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_13/ai_n25408229]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: VeriSign (Nasdaq: VRSN), Google (Nasdaq: GOOG), Osiris Therapeutics, Inc. (Nasdaq: OSIR),...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 13 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/analyst.html"><![CDATA[analyst]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/google+inc..html"><![CDATA[Google Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/newsletter.html"><![CDATA[newsletter]]></category>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/verisign+inc..html"><![CDATA[VeriSign Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRSN</category>
		<category domain="tickers">GENZ,GOOG,NDAQ,OSIR,VRSN</category>
	</item>
	<item>
		<title><![CDATA[Turning Pennies into dollars: OTC: HSXI), (OTCBB: RMDX), (NASDAQ: OSIR), (NASDAQ: EXAC), (PINKSHEETS: WTVN).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200802/ai_n25257475]]></link>
		<description><![CDATA[M2 PRESSWIRE-28 February 2008-RealPennies.com: Turning Pennies into  dollars: OTC: HSXI), (OTCBB: RMDX), (NASDAQ: OSIR), (NASDAQ: EXAC),  (PINKSHEETS: WTVN).C1994-2008 M2 COMMUNICATIONS LTD     RDATE:28022008     Are you a public company looking for exposure? Contact  RealPennies.com - 1.800.940.6559     For...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 28 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/director.html"><![CDATA[director]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/exactech+inc..html"><![CDATA[Exactech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/international+data+corp..html"><![CDATA[International Data Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/monitoring.html"><![CDATA[monitoring]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/osiris+therapeutics+inc..html"><![CDATA[Osiris Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[sales]]></category>
		<category domain="http://resources.bnet.com/topic/stem-cell.html"><![CDATA[stem-cell]]></category>
		<category domain="http://resources.bnet.com/topic/tvs.html"><![CDATA[TVs]]></category>
		<category domain="http://resources.bnet.com/topic/u.s..html"><![CDATA[U.S.]]></category>
		<category domain="http://resources.bnet.com/topic/wi-fi.html"><![CDATA[Wi-Fi]]></category>
		<category domain="http://resources.bnet.com/topic/wireless.html"><![CDATA[WIRELESS]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EXAC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIR</category>
		<category domain="tickers">EXAC,NDAQ,OSIR</category>
	</item>
</channel>
</rss>
